Vomaris Patent Estate Expands

VOMARIS PATENT ESTATE GROWS TO SIX ISSUED U.S. PATENTS AND THREE GRANTED INTERNATIONAL PATENTS WITH U.S. PAT. NO. 8,224,439 Vomaris Innovations, Inc, a leading regenerative medicine company...

Read More »

Vomaris Innovations, Inc. Names New CEO

Vomaris Innovations, Inc, a leading regenerative medicine company focusing on wound care with bioelectric technology, has named Michael P. Nagel as its new President and Chief Executive Officer. Mr....

Read More »

K-128 Rev. A – Last updated: May 2024

Thank you for contacting Vomaris.
We will respond to you within 48 hours.

Skip to content